Dongkyoo Park

1.2k total citations
19 papers, 802 citations indexed

About

Dongkyoo Park is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dongkyoo Park has authored 19 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dongkyoo Park's work include Cancer therapeutics and mechanisms (9 papers), Cell death mechanisms and regulation (6 papers) and DNA Repair Mechanisms (5 papers). Dongkyoo Park is often cited by papers focused on Cancer therapeutics and mechanisms (9 papers), Cell death mechanisms and regulation (6 papers) and DNA Repair Mechanisms (5 papers). Dongkyoo Park collaborates with scholars based in United States, China and South Korea. Dongkyoo Park's co-authors include Xingming Deng, Gabriel Sica, Walter J. Curran, Maohua Xie, Suresh S. Ramalingam, Andrew T. Magis, Taofeek K. Owonikoko, Jun Zhang, Shuo You and Fadlo R. Khuri and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Dongkyoo Park

19 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongkyoo Park United States 14 545 287 137 93 90 19 802
Monish Ram Makena United States 13 562 1.0× 295 1.0× 196 1.4× 86 0.9× 63 0.7× 27 839
Maria Serena Roca Italy 14 457 0.8× 184 0.6× 152 1.1× 68 0.7× 104 1.2× 28 709
Suk‐young Lee South Korea 16 395 0.7× 216 0.8× 148 1.1× 60 0.6× 111 1.2× 43 719
Alessandro Colapietro Italy 17 370 0.7× 262 0.9× 116 0.8× 85 0.9× 76 0.8× 34 728
Suji Han South Korea 14 478 0.9× 222 0.8× 154 1.1× 84 0.9× 54 0.6× 29 752
Céline Van Themsche Canada 18 544 1.0× 246 0.9× 228 1.7× 118 1.3× 49 0.5× 25 894
Huda H. Al‐Khalaf Saudi Arabia 17 457 0.8× 353 1.2× 223 1.6× 74 0.8× 71 0.8× 30 850
Kyoung Eun Baek South Korea 13 432 0.8× 218 0.8× 109 0.8× 67 0.7× 69 0.8× 18 633
Yurong Zhang China 11 413 0.8× 199 0.7× 153 1.1× 135 1.5× 91 1.0× 32 656
Haijun Zhang China 15 544 1.0× 211 0.7× 229 1.7× 70 0.8× 154 1.7× 24 870

Countries citing papers authored by Dongkyoo Park

Since Specialization
Citations

This map shows the geographic impact of Dongkyoo Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongkyoo Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongkyoo Park more than expected).

Fields of papers citing papers by Dongkyoo Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongkyoo Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongkyoo Park. The network helps show where Dongkyoo Park may publish in the future.

Co-authorship network of co-authors of Dongkyoo Park

This figure shows the co-authorship network connecting the top 25 collaborators of Dongkyoo Park. A scholar is included among the top collaborators of Dongkyoo Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongkyoo Park. Dongkyoo Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Park, Dongkyoo, Andrew T. Magis, Guo Chen, et al.. (2021). Discovery of Small Molecule Bak Activator for Lung Cancer Therapy. Theranostics. 11(17). 8500–8516. 23 indexed citations
2.
Xie, Maohua, Dongkyoo Park, Gabriel Sica, & Xingming Deng. (2020). Bcl2-induced DNA replication stress promotes lung carcinogenesis in response to space radiation. Carcinogenesis. 41(11). 1565–1575. 7 indexed citations
3.
Chen, Guo, Dongkyoo Park, Andrew T. Magis, et al.. (2019). Mcl-1 Interacts with Akt to Promote Lung Cancer Progression. Cancer Research. 79(24). 6126–6138. 27 indexed citations
4.
Xu, Ke, Dongkyoo Park, Andrew T. Magis, et al.. (2019). Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy. Molecular Cancer. 18(1). 85–85. 53 indexed citations
5.
Chen, Guo, Andrew T. Magis, Ke Xu, et al.. (2018). Abstract 328: Targeting Mcl-1 enhances DNA replication stress sensitivity for cancer therapy. Cancer Research. 78(13_Supplement). 328–328. 2 indexed citations
6.
Chen, Guo, Andrew T. Magis, Ke Xu, et al.. (2017). Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy. Journal of Clinical Investigation. 128(1). 500–516. 52 indexed citations
7.
Deng, Jiusheng, Dongkyoo Park, Ajay K. Nooka, et al.. (2016). BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth. Oncotarget. 7(19). 27753–27763. 18 indexed citations
8.
Nagaraju, Ganji Purnachandra, Balney Rajitha, Sheik Aliya, et al.. (2016). The role of adiponectin in obesity-associated female-specific carcinogenesis. Cytokine & Growth Factor Reviews. 31. 37–48. 46 indexed citations
9.
Zhang, Jun, Qun Dai, Dongkyoo Park, & Xingming Deng. (2016). Targeting DNA Replication Stress for Cancer Therapy. Genes. 7(8). 51–51. 64 indexed citations
10.
Deng, Jiusheng, et al.. (2015). Small Molecule Bda-366 As a Bcl2-BH4 Antagonist for Multiple Myeloma Therapy. Blood. 126(23). 2049–2049. 1 indexed citations
11.
Park, Dongkyoo, Rui Li, Maohua Xie, et al.. (2015). Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy. Cancer Cell. 27(6). 852–863. 96 indexed citations
12.
Zhang, Jun, Dongkyoo Park, Dong M. Shin, & Xingming Deng. (2015). Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities. Acta Biochimica et Biophysica Sinica. 48(1). 11–16. 13 indexed citations
13.
Xie, Maohua, Dongkyoo Park, Shuo You, et al.. (2015). Bcl2 inhibits recruitment of Mre11 complex to DNA double-strand breaks in response to high-linear energy transfer radiation. Nucleic Acids Research. 43(2). 960–972. 18 indexed citations
14.
Xin, Meiguo, Rui Li, Maohua Xie, et al.. (2014). Small-molecule Bax agonists for cancer therapy. Nature Communications. 5(1). 4935–4935. 102 indexed citations
15.
Higgins, Kristin, Dongkyoo Park, Gee Young Lee, Walter J. Curran, & Xingming Deng. (2014). Exercise‐induced lung cancer regression: Mechanistic findings from a mouse model. Cancer. 120(21). 3302–3310. 52 indexed citations
16.
You, Shuo, Rui Li, Dongkyoo Park, et al.. (2013). Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer. Molecular Cancer Therapeutics. 13(3). 606–616. 147 indexed citations
17.
Park, Dongkyoo, Andrew T. Magis, Rui Li, et al.. (2013). Novel Small-Molecule Inhibitors of Bcl-XL to Treat Lung Cancer. Cancer Research. 73(17). 5485–5496. 59 indexed citations
18.
Choi, Inho, Sung Dae Kim, Bumrae Cho, et al.. (2007). Xenogeneic interaction between human CD40L and porcine CD40 activates porcine endothelial cells through NF-κB signaling. Molecular Immunology. 45(2). 575–580. 18 indexed citations
19.
Choi, Inho, Bumrae Cho, Sung Dae Kim, et al.. (2005). Molecular cloning, expression and functional characterization of miniature swine CD86. Molecular Immunology. 43(5). 480–486. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026